Cohort demographic characteristics and renal function
| Characteristic . | SCD . | Control . |
|---|---|---|
| Total, n | 77 | 10 |
| Genotype∗ | ||
| S-beta | 13 (10) | |
| SC | 19.5 (15) | |
| SS | 67.5 (52) | |
| AA | 0 (0) | 100 (10) |
| Gender∗ | ||
| Female | 53.2 (41) | 50 (5) |
| Male | 46.8 (36) | 50 (5) |
| Race∗ | ||
| African American | 96.1 (74) | 60 (6) |
| Age, y | ||
| Median (range) | 42.5 (18-67) | 36 (30-50) |
| Prevalence of CKD∗ | 36.3 (28) | 0 (0) |
| Prevalence of CKD by stage† | ||
| Stage 1 | 64.3 (18/28) | |
| Stage 2 | 14.3 (4/28) | |
| Stage 3 | 17.9 (5/28) | |
| Stage 4 | 0 (0/28) | |
| Stage 5 | 3.6 (1/28) | |
| Prevalence of CKD by age (years)† | ||
| <25 | 35.7 (5/14) | |
| 25-44 | 30 (12/40) | |
| 45-60 | 50 (8/16) | |
| >60 | 42.8 (3/7) | |
| Prevalence of CKD by gender† | ||
| Female | 34.1 (14/41) | |
| Male | 38.9 (14/36) |
| Characteristic . | SCD . | Control . |
|---|---|---|
| Total, n | 77 | 10 |
| Genotype∗ | ||
| S-beta | 13 (10) | |
| SC | 19.5 (15) | |
| SS | 67.5 (52) | |
| AA | 0 (0) | 100 (10) |
| Gender∗ | ||
| Female | 53.2 (41) | 50 (5) |
| Male | 46.8 (36) | 50 (5) |
| Race∗ | ||
| African American | 96.1 (74) | 60 (6) |
| Age, y | ||
| Median (range) | 42.5 (18-67) | 36 (30-50) |
| Prevalence of CKD∗ | 36.3 (28) | 0 (0) |
| Prevalence of CKD by stage† | ||
| Stage 1 | 64.3 (18/28) | |
| Stage 2 | 14.3 (4/28) | |
| Stage 3 | 17.9 (5/28) | |
| Stage 4 | 0 (0/28) | |
| Stage 5 | 3.6 (1/28) | |
| Prevalence of CKD by age (years)† | ||
| <25 | 35.7 (5/14) | |
| 25-44 | 30 (12/40) | |
| 45-60 | 50 (8/16) | |
| >60 | 42.8 (3/7) | |
| Prevalence of CKD by gender† | ||
| Female | 34.1 (14/41) | |
| Male | 38.9 (14/36) |